FI853389A0 - TUMOERLAEKEMEDEL OCH FOERFARANDE FOER DESS FRAMSTAELLNING. - Google Patents

TUMOERLAEKEMEDEL OCH FOERFARANDE FOER DESS FRAMSTAELLNING.

Info

Publication number
FI853389A0
FI853389A0 FI853389A FI853389A FI853389A0 FI 853389 A0 FI853389 A0 FI 853389A0 FI 853389 A FI853389 A FI 853389A FI 853389 A FI853389 A FI 853389A FI 853389 A0 FI853389 A0 FI 853389A0
Authority
FI
Finland
Prior art keywords
tumoerlaekemedel
foerfarande foer
och foerfarande
foer dess
dess framstaellning
Prior art date
Application number
FI853389A
Other languages
Finnish (fi)
Other versions
FI88360C (en
FI853389L (en
FI88360B (en
Inventor
Klaus Bosslet
Hans-Harald Sedlacek
Original Assignee
Behringwerke Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Behringwerke Ag filed Critical Behringwerke Ag
Publication of FI853389A0 publication Critical patent/FI853389A0/en
Publication of FI853389L publication Critical patent/FI853389L/en
Application granted granted Critical
Publication of FI88360B publication Critical patent/FI88360B/en
Publication of FI88360C publication Critical patent/FI88360C/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0011—Cancer antigens

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Oncology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
  • Window Of Vehicle (AREA)
  • Diaphragms For Electromechanical Transducers (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)

Abstract

The process entails either tumour cells which carry antigens which are bound by the monoclonal antibodies described in German Offenlegungsschrift 33 29 184 being dried or stabilised by a chemical treatment, or antigens being isolated from human cells using these monoclonal antibodies, and converted into a therapeutic agent, adding neuraminidase where appropriate.
FI853389A 1984-09-06 1985-09-04 Process for the preparation of tumor drugs FI88360C (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19843432714 DE3432714A1 (en) 1984-09-06 1984-09-06 TUMOR THERAPEUTICS AND METHOD FOR THE PRODUCTION THEREOF
DE3432714 1984-09-06

Publications (4)

Publication Number Publication Date
FI853389A0 true FI853389A0 (en) 1985-09-04
FI853389L FI853389L (en) 1986-03-07
FI88360B FI88360B (en) 1993-01-29
FI88360C FI88360C (en) 1993-05-10

Family

ID=6244749

Family Applications (1)

Application Number Title Priority Date Filing Date
FI853389A FI88360C (en) 1984-09-06 1985-09-04 Process for the preparation of tumor drugs

Country Status (13)

Country Link
EP (1) EP0173951B1 (en)
JP (1) JPS6168427A (en)
AT (1) ATE64531T1 (en)
CA (1) CA1277600C (en)
DE (2) DE3432714A1 (en)
DK (1) DK172253B1 (en)
ES (1) ES8704082A1 (en)
FI (1) FI88360C (en)
GR (1) GR852149B (en)
IE (1) IE58638B1 (en)
IL (1) IL76289A (en)
PT (1) PT81093B (en)
ZA (1) ZA856807B (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3806565A1 (en) * 1988-03-01 1989-09-14 Deutsches Krebsforsch VIRUS-MODIFIED TUMOR VACCINES FOR THE IMMUNOTHERAPY OF TUMOR METAL KEYS
AT398900B (en) * 1991-02-12 1995-02-27 Pekar Rudolf Dr Vaccine for immunotherapy
US7070782B1 (en) 1992-11-05 2006-07-04 Sloan-Kettering Institute For Cancer Research Prostate-specific membrane antigen
EP0668777B2 (en) * 1992-11-05 2011-02-09 Sloan-Kettering Institute For Cancer Research Prostate-specific membrane antigen
US7105159B1 (en) 1992-11-05 2006-09-12 Sloan-Kettering Institute For Cancer Research Antibodies to prostate-specific membrane antigen
US6953668B1 (en) 1992-11-05 2005-10-11 Sloan-Kettering Institute For Cancer Research Prostate-specific membrane antigen
US6569432B1 (en) 1995-02-24 2003-05-27 Sloan-Kettering Institute For Cancer Research Prostate-specific membrane antigen and uses thereof
DE19506483A1 (en) * 1995-02-24 1996-08-29 Jens Dr Dr Atzpodien Antitumour vaccines
AU717937B2 (en) 1995-02-24 2000-04-06 Sloan-Kettering Institute For Cancer Research Prostate-specific membrane antigen and uses thereof
US20050215472A1 (en) 2001-10-23 2005-09-29 Psma Development Company, Llc PSMA formulations and uses thereof
WO2003034903A2 (en) 2001-10-23 2003-05-01 Psma Development Company, L.L.C. Psma antibodies and protein multimers
CN1315536C (en) * 2002-09-13 2007-05-16 李进 Novel vaccine of tumor antigen, its preparation method and vaccine composition

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4152410A (en) * 1975-09-03 1979-05-01 Eisai Co., Ltd. Diagnosis reagent for neoplasm and method for diagnosis of neoplasm
DE2643215A1 (en) * 1976-09-25 1978-04-06 Bayer Ag CANCEROSTATICALLY EFFECTIVE PREPARATIONS FROM TUMOR CELLS AND A METHOD FOR THEIR PRODUCTION
ZA776822B (en) * 1976-11-24 1979-06-27 D Mccollester Vaccine and method for immunotherapy of neoplastic disease
DE2918927A1 (en) * 1979-05-10 1980-11-20 Hans Prof Dr Limburg MEDICINAL PRODUCT FOR TREATING CARCINOMAS AND METHOD FOR THE PRODUCTION THEREOF
US4446122A (en) * 1979-12-28 1984-05-01 Research Corporation Purified human prostate antigen
US4468457A (en) * 1981-06-01 1984-08-28 David M. Goldenberg Method for producing a CSAp tryptic peptide and anti-CSAp antibodies
DE3329184A1 (en) * 1983-08-12 1985-02-21 Behringwerke Ag, 3550 Marburg MONOCLONAL ANTIBODIES WITH SPECIFICITY FOR MEMBRANE-ASSOCIATED ANTIGENS
DE3416774A1 (en) * 1984-05-07 1985-11-14 Behringwerke Ag, 3550 Marburg MONOCLONAL ANTIBODIES, METHOD FOR THE PRODUCTION THEREOF AND THEIR USE

Also Published As

Publication number Publication date
CA1277600C (en) 1990-12-11
DK402485A (en) 1986-03-07
FI88360C (en) 1993-05-10
DE3583265D1 (en) 1991-07-25
DK402485D0 (en) 1985-09-03
FI853389L (en) 1986-03-07
IE852191L (en) 1986-03-06
IL76289A (en) 1992-01-15
PT81093B (en) 1988-07-01
IL76289A0 (en) 1986-01-31
ES8704082A1 (en) 1987-03-16
DE3432714A1 (en) 1986-04-24
ZA856807B (en) 1986-04-30
ATE64531T1 (en) 1991-07-15
EP0173951A3 (en) 1988-06-08
EP0173951B1 (en) 1991-06-19
ES546701A0 (en) 1987-03-16
FI88360B (en) 1993-01-29
JPS6168427A (en) 1986-04-08
GR852149B (en) 1986-01-03
EP0173951A2 (en) 1986-03-12
PT81093A (en) 1985-10-01
IE58638B1 (en) 1993-10-20
DK172253B1 (en) 1998-02-09

Similar Documents

Publication Publication Date Title
DK69890A (en) MONOCLONAL ANTIBODIES REACTIVE WITH CACHETIN
DE3584559D1 (en) THERAPEUTIC ANTIBODY CONJUGATES.
BR8801396A (en) COMPOUND, RADIATION POLYMERIZABLE MIXTURE AND REGISTRATION MATERIAL
NO862641D0 (en) MONOCLONAL ANTIBODY FOR AN ANTI-TREATED HUMAN CARCINOMA TUMOR.
NO863313D0 (en) MIXTURE TREATMENT DEVICE.
DE3783277D1 (en) MONOCLONAL ANTIBODY AGAINST HUMAN LUNG CARCINOMA.
DE3854502D1 (en) AGAINST HIV-ANTIGENT SPECIFIC MONOCLONAL ANTIBODIES.
FI853389L (en) TUMOERLAEKEMEDEL OCH FOERFARANDE FOER DESS FRAMSTAELLNING.
OA08485A (en) Monoclonal antibodies and antigen for human non-small cell lung carcinoma and certain other human carcinomas.
DE3482905D1 (en) MONOCLONAL ANTIBODIES AGAINST LUNG CANCER OF THE "NON-SMALL-CELL" TYPE.
NL171327C (en) MAGNETIC LUMBAR BELT FOR MEDICAL PURPOSES.
IT1207589B (en) COMPOSITION OF CROSS-PROTECTIVE HUMAN MONOCLONAL ANTIBODIES.
DE3586216D1 (en) BREAST TUMOR ASSOCIATED ANTIQUE AND MONOCLONAL ANTIBODIES THEREFOR.
DK169987D0 (en) HUMAN TUMOR-ASSOCIATED ANTIGEN, CA-OU1
DE2964386D1 (en) Therapeutic means for immune complex diseases
EP0042428A4 (en) Purified human prostate antigen.
DE3888604D1 (en) Monoclonal antibodies against antithrombin binding substance and its uses.
DE3785795D1 (en) MONOCLONAL ANTI-HUMAN CANCER ANTIBODIES.
FI834429A (en) FRAMSTAELLNING OCH THERAPEUTIC TILLAEMPNING AV 3 ', 5'-DIARABINOSIDER.
DK182188D0 (en) HUMANT TUMOR ASSOCIATED ANTIGEN
NO873274D0 (en) CLOSED TOWNSHIP AND PROCEDURE FOR CREATING THIS.
NO885392L (en) HUMANT TUMOR-ASSOCIATED ANTIGEN.
DK354288D0 (en) CHEMICAL ANTIBODY WITH SPECIFICITY OVER HUMANT TUMOR ANTIGEN
IT7919222A0 (en) PROCEDURE FOR PRODUCING HUMAN ANTIBODIES.
GB8823081D0 (en) Human monoclonal antibodies specifically recognizing rabies virus cells cells producing the same formulations containing the same

Legal Events

Date Code Title Description
BB Publication of examined application
MM Patent lapsed

Owner name: BEHRINGWERKE AKTIENGESELLSCHAFT